Iron replacement therapy: do we need new guidelines?

Area of Science:

• Hematology
• Internal Medicine
• Nutritional Science

Background:

• Iron deficiency anemia (IDA) is a prevalent global health issue, affecting approximately one-third of the world's population.
• Half of all anemia cases are attributed to iron deficiency, highlighting its significance.
• Recent advancements in intravenous iron preparations have created uncertainty regarding optimal treatment protocols compared to oral iron therapy.

Purpose of the Study:

• To address the lack of detailed guidance in existing literature regarding the initiation and cessation of iron replacement therapy.
• To explore the optimal management of iron deficiency anemia based on underlying causes and co-existing medical conditions.
• To identify key areas for improvement in future clinical guidelines for iron therapy.

Main Methods:

• Review of existing international anemia and iron deficiency guidelines.
• Analysis of current therapeutic approaches for iron replacement.
• Identification of gaps in evidence-based recommendations for iron therapy.

Main Results:

• Existing guidelines offer limited detail on specific therapeutic endpoints (start/stop points) for iron therapy.
• There is a need for tailored treatment strategies considering the etiology of iron deficiency and patient comorbidities.
• Current recommendations do not adequately address follow-up protocols for relapse or patient selection for treatment.

Conclusions:

• Future guideline revisions must clarify assessment of treatment need, optimal timing for initiating and terminating iron therapy, and appropriate follow-up intervals.
• Guidelines should specify recommended dosages and types of iron therapy, differentiating between oral and intravenous routes.
• Consideration should be given to identifying patient populations who may not require iron treatment or specific therapeutic interventions.